NYSE:OCR Omnicare (OCR) Stock Price, News & Analysis → FW: 234x Gain (From Weiss Ratings) (Ad) Free OCR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Omnicare alerts: Email Address Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… About Omnicare Stock (NYSE:OCR)Omnicare, Inc. is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG), each serving different customer populations. Through LTC, the Company is a provider of pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. As of December 31, 2014, LTC provided pharmacy services in the United States in 47 states and the District of Columbia. The Specialty Care Group (SCG) operates across a spectrum of the healthcare continuum, serving the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Its SCG services are primarily focused on the specialty pharmaceutical market and incorporate four platforms: brand support services, supply chain solutions, patient support services and specialty pharmacy.Read More Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… OCR Stock News HeadlinesApril 24, 2024 | bbc.co.ukPythagoras' theorem - OCRMarch 19, 2024 | bbc.co.ukTransformation of curves - Higher - OCRMay 4, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.February 29, 2024 | bbc.co.ukSample exam questions - interacting with Earth systems - OCR GFebruary 28, 2024 | bbc.co.ukRadioactivity - OCR Gateway RadiationFebruary 23, 2024 | bbc.co.ukThe mobilisation of the US people during World War Two - OCR AFebruary 23, 2024 | bbc.co.ukHistory - OCR AFebruary 23, 2024 | bbc.co.ukBritain since c.1900 and the people's health - OCR BMay 4, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.February 18, 2024 | bbc.co.ukUnits and data representation - OCRFebruary 15, 2024 | bbc.co.ukEnergy, temperature and change of state - OCR GatewayFebruary 11, 2024 | bbc.co.ukForces and elasticity - OCR GatewayFebruary 10, 2024 | bbc.co.ukNature of human life - OCRFebruary 6, 2024 | bbc.co.ukSolving simultaneous equations - OCRFebruary 5, 2024 | bbc.co.ukLight - OCR Gateway ColourFebruary 3, 2024 | bbc.co.ukRefugees and ‘enemy aliens’ in the Modern Era, 1900 - 1947 - OCR BFebruary 2, 2024 | bbc.co.ukWhole numbers - OCR Order of operationsJanuary 22, 2024 | bbc.co.ukWhat determines the current in an electric circuit? - OCR 21st CenturyJanuary 20, 2024 | bbc.co.ukSupplying the cell - OCR GatewayJanuary 20, 2024 | bbc.co.ukSample exam questions - organism level systems - OCR GatewayJanuary 16, 2024 | bbc.co.ukVectors - OCRJanuary 15, 2024 | bbc.co.ukBach: Brandenburg concerto No.5, third movement - OCRJanuary 10, 2024 | bbc.co.ukExperiences of immigrants in the Early Modern era, 1500-1750 - OCR ADecember 25, 2023 | bbc.co.ukImmigration in the Early Modern era, 1500-1750 overview - OCR ADecember 20, 2023 | bbc.co.ukMomentum, work and power - OCR GatewayDecember 9, 2023 | bbc.co.ukWeimar Germany, 1924-1929 - OCR ANovember 5, 2023 | bbc.co.ukLife in Nazi Germany, 1933-1939 - OCR BSee More Headlines Receive OCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Omnicare and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryHealth Care Services Current SymbolNYSE:OCR CUSIP68190410 CIK353230 Webwww.omnicare.com Phone+1-513-7192600FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report OCR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Omnicare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Omnicare investors own include TiVo (TIVO), Incyte (INCY), Booking (BKNG), Depomed (DEPO), Electronic Arts (EA), Endo International (ENDP), Horizon Therapeutics Public (HZNP), ImmunoGen (IMGN), Ionis Pharmaceuticals (IONS) and Lexicon Pharmaceuticals (LXRX). This page (NYSE:OCR) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omnicare Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.